Back
Rocket Pharmaceuticals Stock Predictions
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
28
RCKT
Rocket Pharmaceuticals
Last Price:
$6.19
Seasonality Move:
9.99%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Rocket Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Rocket Pharmaceuticals has on average historically risen by 27.9% based on the past 10 years of stock performance.
-
Rocket Pharmaceuticals has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Rocket Pharmaceuticals Stock Undervalued?The current Rocket Pharmaceuticals [RCKT] share price is $6.62. The Score for RCKT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RCKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Rocket Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Rocket Pharmaceuticals has on average historically risen by 27.9% based on the past 10 years of stock performance.
Rocket Pharmaceuticals Stock Rating
Sell
28
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals overpriced?
-
Rocket Pharmaceuticals has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Rocket Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rocketpharma.com
52-Week Data
52-Week High:
26.98
52-Week Low:
4.55
Prediction Charts
Market Cap:
712.7M
Price in USD:
6.62
Volume:
4.3M
Beta:
1.57
Technical Analysis
SMA50:
7.27
SMA100:
9.12
SMA200:
13.49
52-Wk Change:
-71.35%
Stock Predictions
-
Is Rocket Pharmaceuticals stock public?Yes, Rocket Pharmaceuticals is a publicly traded company.
-
What is the Rocket Pharmaceuticals stock quote today?The Rocket Pharmaceuticals stock price is 6.62 USD today.
-
How to buy Rocket Pharmaceuticals stock online?You can buy Rocket Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-24 | 7.15 | 7.43 | 7.50 | 7.11 |
| Apr-25 | 7.30 | 7.23 | 7.40 | 7.13 |
| Apr-28 | 7.23 | 7.16 | 7.47 | 6.95 |
| Apr-29 | 7.16 | 7.28 | 7.37 | 7.04 |
| Apr-30 | 7.16 | 7.63 | 7.65 | 7.01 |
| May-1 | 7.65 | 7.86 | 7.93 | 7.31 |
| May-2 | 7.97 | 8.01 | 8.26 | 7.90 |
| May-5 | 8.00 | 7.85 | 8.19 | 7.81 |
| May-6 | 7.73 | 6.31 | 7.77 | 6.29 |
| May-7 | 6.36 | 6.70 | 6.80 | 6.21 |
| May-8 | 6.81 | 7.04 | 7.29 | 6.70 |
| May-9 | 7.01 | 6.99 | 7.30 | 6.85 |
| May-12 | 7.25 | 7.00 | 7.39 | 6.96 |
| May-13 | 7.00 | 6.62 | 7.13 | 6.23 |
Rocket Pharmaceuticals Earnings
Rocket Pharmaceuticals Earnings Report: Per Share Rocket Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Rocket Pharmaceuticals Forecast Revenue Growth
Rocket Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Rocket Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.60 per share, and an increase next year of $0.61 per share.
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.